DCM
WST icon

Davidson Capital Management’s West Pharmaceutical WST Stock Holding History

Davidson Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-8,926
Closed -$2.94M – 88
2024
Q2 		$2.94M Buy
8,926
+2,272
+34% +$803K 0.91% 42
2024
Q1 		$2.63M Buy
6,654
+45
+0.7% +$16.6K 0.85% 32
2023
Q4 		$2.33M Buy
6,609
+2,366
+56% +$837K 0.85% 37
2023
Q3 		$1.59M Sell
4,243
-22
-0.5% -$8.51K 0.79% 31
2023
Q2 		$1.63M Buy
4,265
+234
+6% +$83.6K 0.81% 23
2023
Q1 		$1.4M Buy
4,031
+927
+30% +$271K 0.85% 29
2022
Q4 		$731K Buy
+3,104
New +$736K 0.5% 38

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Davidson Capital Management's WST Position: Q3 2024 in Review

Davidson Capital Management sold out of West Pharmaceutical (WST) in Q3 2024, closing a stake of 8,926 shares — an estimated $2.94M sold.

Davidson Capital Management first reported a position in WST in Q4 2022 and held it in 7 quarters. The position peaked at $2.94M in Q2 2024. 730 funds tracked by Wall St. Rank hold WST as of Q3 2024.

  • Davidson Capital Management reported no remaining West Pharmaceutical position as of Q3 2024 after selling out during the quarter.
  • Davidson Capital Management sold 8,926 West Pharmaceutical shares in Q3 2024, an estimated $2.94M.
  • Davidson Capital Management first reported a position in West Pharmaceutical in Q4 2022 and held it in 7 quarters.
  • Davidson Capital Management's West Pharmaceutical position peaked at $2.94M in Q2 2024.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2024.

Based on Davidson Capital Management's 13F filing for Q3 2024, filed 25 Oct 2024.